Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients

Summary

This proposed study will use previous study results to guide the development and evaluation of interventions to improve CRC screening acceptance. The proposed study will evaluate the impact of three interventions to promote CRC screening among siblings in this increased-risk group, who are not currently compliant with CRC screening guidelines: 1) a generic print intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored telephone counseling intervention.

Conditions

• Colorectal
• Cancer
• Screening
• Intervention

Interventions

OTHER

Generic Print Intervention

Generic Print Intervention: The generic print intervention will consist of the pamphlet, "Colorectal Cancer Screening Saves Lives" published by the Center for Disease Control that will be mailed to the participant.

OTHER

Tailored Print Intervention

Tailored Print Intervention: The tailored print intervention will consist of a cover letter detailing the participant's stage of readiness along with a color pamphlet with information personally tailored for the individual participant.

OTHER

Tailored print plus tailored phone intervention

Tailored print plus tailored phone intervention: The tailored print plus tailored telephone intervention will consist of a phone counseling session and the tailored print information described above. The tailored print material will serve as a guide during the telephone counseling contact and a reinforcement of the information.

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• Fox Chase Cancer Center

  collaborator OTHER

• Icahn School of Medicine at Mount Sinai

  collaborator OTHER

• Lombardi Comprehensive Cancer Center

  collaborator OTHER

• Micromass Communications, Cary, NC

  collaborator UNKNOWN

• University of Pennsylvania

  collaborator OTHER

• Christiana Care Health Services

  collaborator OTHER

• Pinnacle Health Regional Cancer Center, Harrisburg, PA

  collaborator UNKNOWN

• Temple University

  collaborator OTHER

• St. Mary Regional Cancer Center, Langhorne, PA

  collaborator UNKNOWN

• South Jersey Regional Cancer Center, Bridgton, New Jersey

  collaborator UNKNOWN

• Hunterdon Cancer Center

  collaborator UNKNOWN

• Northeast Regional Cancer Institute

  collaborator OTHER

• Virtua Memorial Hospital and Virtua West

  collaborator UNKNOWN

• Jersey Hospital

  collaborator UNKNOWN

• Rutgers Cancer Institute of New Jersey

  collaborator OTHER

• Massachusetts General Hospital

  collaborator OTHER

• Main Line Health

  collaborator OTHER

• Roswell Park Cancer Institute

  collaborator OTHER

• HematologyOncology

  collaborator UNKNOWN

• Associates of Central New York

  collaborator UNKNOWN

• Augusta University

  collaborator OTHER

• Memorial Sloan Kettering Cancer Center

  lead OTHER

Principal Investigators

• Arnold Markowitz, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age

40 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2003-06-30

Primary Completion

2008-05-31

Completion

2008-05-31

Countries

• United States

Study Locations